We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
-3.05%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$52.7B
AUM Growth
-$2.48B
Cap. Flow
+$256M
Cap. Flow %
0.49%
Top 10 Hldgs %
16.27%
Holding
2,367
New
187
Increased
1,008
Reduced
966
Closed
158

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$237M
2
PFE icon
Pfizer
PFE
+$200M
3
MRNA icon
Moderna
MRNA
+$143M
4
EPAM icon
EPAM Systems
EPAM
+$106M
5
GILD icon
Gilead Sciences
GILD
+$94.7M

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$138M
2
TMO icon
Thermo Fisher Scientific
TMO
+$135M
3
AU icon
AngloGold Ashanti
AU
+$112M
4
COST icon
Costco
COST
+$111M
5
MSFT icon
Microsoft
MSFT
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.94%
2 Healthcare 15.7%
3 Industrials 11.74%
4 Financials 11.69%
5 Consumer Discretionary 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCYT icon
2301
Veracyte
VCYT
$3.72B
-16,105
Closed -$664K
VERI icon
2302
Veritone
VERI
$134M
-10,687
Closed -$240K
VLRS
2303
Controladora Vuela Compania de Aviacion
VLRS
$927M
-82,664
Closed -$1.49M
VMD icon
2304
Viemed Healthcare
VMD
$355M
-15,043
Closed -$79K
WABC icon
2305
Westamerica Bancorp
WABC
$1.35B
-33,880
Closed -$1.96M
WVE icon
2306
Wave Life Sciences
WVE
$1.2B
-77,561
Closed -$244K
XXII
2307
22nd Century Group
XXII
$1.5M
0
-$97K
ZLAB icon
2308
Zai Lab
ZLAB
$2.65B
-123,917
Closed -$7.79M
DAY
2309
DELISTED
Dayforce
DAY
-5,140
Closed -$537K
AIFU
2310
AIFU Inc
AIFU
$220M
-185
Closed -$538K
VOXX
2311
DELISTED
VOXX International Corporation Class A
VOXX
-28,276
Closed -$288K
ITI
2312
DELISTED
Iteris, Inc.
ITI
-94,414
Closed -$378K
SEEL
2313
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
-25
Closed -$156K
ASXC
2314
DELISTED
Asensus Surgical, Inc.
ASXC
-203,206
Closed -$226K
LL
2315
DELISTED
LL Flooring Holdings, Inc.
LL
-36,013
Closed -$615K
NGM
2316
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
-10,975
Closed -$194K
NSTG
2317
DELISTED
NanoString Technologies, Inc.
NSTG
-8,137
Closed -$344K
QUOT
2318
DELISTED
Quotient Technology Inc
QUOT
-105,892
Closed -$786K
AMRS
2319
DELISTED
Amyris Inc.
AMRS
-39,539
Closed -$214K
NMTR
2320
DELISTED
9 Meters Biopharma
NMTR
-5,415
Closed -$106K
RUTH
2321
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
-16,686
Closed -$332K
MGI
2322
DELISTED
MoneyGram International, Inc. New
MGI
-11,563
Closed -$91K
MYOV
2323
DELISTED
Myovant Sciences Ltd.
MYOV
-18,370
Closed -$286K
RUBY
2324
DELISTED
Rubius Therapeutics, Inc
RUBY
-17,211
Closed -$167K
SRNE
2325
DELISTED
Sorrento Therapeutics, Inc.
SRNE
-16,892
Closed -$79K

Similar funds

AQR Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, AQR Capital Management held 2,367 positions worth $52.7B, down 4.5% from $55.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

AQR Capital Management's Q1 2022 filing shows 187 new, 1,008 increased, 966 reduced and 158 closed positions. Its largest new stake was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M. The largest sale was Target, an estimated $138M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

  • AQR Capital Management's largest Q1 2022 buy was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M.
  • AQR Capital Management added most to Meta Platforms (Facebook) in Q1 2022, an estimated $237M increase.
  • AQR Capital Management's biggest Q1 2022 reduction was Target, cutting an estimated $138M.
  • AQR Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $25.4M.
  • AQR Capital Management's ten largest holdings make up 16% of its $52.7B portfolio in Q1 2022.
  • AQR Capital Management opened 187 new positions and closed 158 in Q1 2022.
  • AQR Capital Management's portfolio value fell 4.5% quarter-over-quarter to $52.7B.

Based on AQR Capital Management's 13F filing for Q1 2022, filed 16 May 2022.